Shares of Covetrus CVET were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 107.69% year over year to $0.27, which beat the estimate of $0.08.
Revenue of $1,026,000,000 up by 1.68% year over year, which beat the estimate of $883,470,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: Aug 11, 2020
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/r6vu55j6
Recent Stock Performance
Company's 52-week high was at $24.13
52-week low: $4.04
Price action over last quarter: Up 92.94%
Company Description
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe, and APAC and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.